The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Cited by (1,513)

Items 101–200 of 1,513

1. Automated classification of Alzheimer’s disease and mild cognitive impairment using a single MRI and deep neural networks.
   Basaia, Silvia, Agosta, Federica, Wagner, Luca, Canu, Elisa, Magnani, Giuseppe, Santangelo, Roberto, Filippi, Massimo · 2019 · NeuroImage: Clinical
2. Tau and Aβ imaging, CSF measures, and cognition in Alzheimer’s disease
   Brier, Matthew R., Gordon, Brian, Friedrichsen, Karl, McCarthy, John, Stern, Ari, Christensen, Jon, Owen, Christopher, Aldea, Patricia, Su, Yi, Hassenstab, Jason et al. · 2016 · Science Translational Medicine
3. Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic
   Hampel, Harald, O’Bryant, Sid E., Molinuevo, José L., Zetterberg, Henrik, Masters, Colin L., Lista, Simone, Kiddle, Steven J., Batrla, Richard, Blennow, Kaj · 2018 · Nature Reviews Neurology
4. Application of Graph Theory for Identifying Connectivity Patterns in Human Brain Networks: A Systematic Review
   Farzad V. Farahani, Waldemar Karwowski, Nichole Renee Lighthall · 2019 · Frontiers in Neuroscience
5. New insights into atypical Alzheimer's disease in the era of biomarkers
   Graff-Radford, Jonathan, Yong, Keir X X, Apostolova, Liana G, Bouwman, Femke H, Carrillo, Maria, Dickerson, Bradford C, Rabinovici, Gil D, Schott, Jonathan M, Jones, David T, Murray, Melissa E · 2021 · The Lancet Neurology
6. Alzheimer's disease drug development pipeline: 2018
   Cummings, Jeffrey, Lee, Garam, Ritter, Aaron, Zhong, Kate · 2018 · Alzheimer's & Dementia: Translational Research & Clinical Interventions
7. Prevalence of Amyloid PET Positivity in Dementia Syndromes: A Meta-analysis
   Ossenkoppele, Rik, Jansen, Willemijn J., Rabinovici, Gil D., Knol, Dirk L., van der Flier, Wiesje M., van Berckel, Bart N. M., Scheltens, Philip, Visser, Pieter Jelle, Verfaillie, Sander C. J., Zwan, Marissa D. et al. · 2015 · JAMA
8. Epidemiologic studies of modifiable factors associated with cognition and dementia: systematic review and meta-analysis
   Beydoun, May A, Beydoun, Hind A, Gamaldo, Alyssa A, Teel, Alison, Zonderman, Alan B, Wang, Youfa · 2014 · BMC Public Health
9. Recommendations for the Nomenclature of Cognitive Change Associated with Anaesthesia and Surgery—2018
   Lisbeth Anne Evered, BRENDAN S. SILBERT, David S. Knopman, David A. Scott, Steven Trent DeKosky, Lars Simon Rasmussen, E. S. Oh, Greg Crosby, Miles Berger, Roderic G. Eckenhoff et al. · 2018 · Anesthesiology
10. Consensus classification of posterior cortical atrophy
    Crutch, Sebastian J., Schott, Jonathan M., Rabinovici, Gil D., Murray, Melissa, Snowden, Julie S., van der Flier, Wiesje M., Dickerson, Bradford C., Vandenberghe, Rik, Ahmed, Samrah, Bak, Thomas H. et al. · 2017 · Alzheimer's & Dementia
11. Bioinorganic Chemistry of Alzheimer’s Disease
    Kasper P. Kepp · 2012 · Chemical Reviews
12. Overview and Findings from the Religious Orders Study
    David Alan Bennett, Julie A. Schneider, Zoe Arvanitakis, Robert S. Wilson · 2012 · Current Alzheimer Research
13. Plasma phospho‐tau181 increases with Alzheimer's disease clinical severity and is associated with tau‐ and amyloid‐positron emission tomography
    Mielke, Michelle M., Hagen, Clinton E., Xu, Jing, Chai, Xiyun, Vemuri, Prashanthi, Lowe, Val J., Airey, David C., Knopman, David S., Roberts, Rosebud O., Machulda, Mary M. et al. · 2018 · Alzheimer's & Dementia
14. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: Implications for diagnostic and therapeutic strategies
    Zhichun Chen, Chunjiu Zhong · 2013 · Progress in Neurobiology
15. Working Memory and Executive Function Decline across Normal Aging, Mild Cognitive Impairment, and Alzheimer’s Disease
    Kirova, Anna-Mariya, Bays, Rebecca B., Lagalwar, Sarita · 2015 · BioMed Research International
16. Prospective longitudinal atrophy in Alzheimer’s disease correlates with the intensity and topography of baseline tau-PET
    La Joie, Renaud, Visani, Adrienne V., Baker, Suzanne L., Brown, Jesse A., Bourakova, Viktoriya, Cha, Jungho, Chaudhary, Kiran, Edwards, Lauren, Iaccarino, Leonardo, Janabi, Mustafa et al. · 2020 · Science Translational Medicine
17. Clinical trials and late‐stage drug development for <scp>A</scp>lzheimer's disease: an appraisal from 1984 to 2014
    Schneider, L. S., Mangialasche, F., Andreasen, N., Feldman, H., Giacobini, E., Jones, R., Mantua, V., Mecocci, P., Pani, L., Winblad, B. et al. · 2014 · Journal of Internal Medicine
18. Memory loss in Alzheimer's disease
    Jahn, Holger · 2013 · Dialogues in Clinical Neuroscience
19. Blood-Brain Barrier Leakage in Patients with Early Alzheimer Disease
    van de Haar, Harm J., Burgmans, Saartje, Jansen, Jacobus F. A., van Osch, Matthias J. P., van Buchem, Mark A., Muller, Majon, Hofman, Paul A. M., Verhey, Frans R. J., Backes, Walter H. · 2016 · Radiology
20. Plasma β-amyloid in Alzheimer's disease and vascular disease
    Janelidze, Shorena, Stomrud, Erik, Palmqvist, Sebastian, Zetterberg, Henrik, van Westen, Danielle, Jeromin, Andreas, Song, Linan, Hanlon, David, Tan Hehir, Cristina A., Baker, David et al. · 2016 · Scientific Reports
21. Mild cognitive impairment and deficits in instrumental activities of daily living: A systematic review
    Jekel, Katrin, Damian, Marinella, Wattmo, Carina, Hausner, Lucrezia, Bullock, Roger, Connelly, Peter J, Dubois, Bruno, Eriksdotter, Maria, Ewers, Michael, Graessel, Elmar et al. · 2015 · Alzheimer's Research &amp; Therapy
22. Alzheimer’s Disease: Past, Present, and Future
    Bondi, Mark W., Edmonds, Emily C., Salmon, David P. · 2017 · Journal of the International Neuropsychological Society
23. Alzheimer’s Disease: Epidemiology and Clinical Progression
    Tahami Monfared, Amir Abbas, Byrnes, Michael J., White, Leigh Ann, Zhang, Quanwu · 2022 · Neurology and Therapy
24. Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers
    Frisoni, Giovanni B, Boccardi, Marina, Barkhof, Frederik, Blennow, Kaj, Cappa, Stefano, Chiotis, Konstantinos, Démonet, Jean-Francois, Garibotto, Valentina, Giannakopoulos, Panteleimon, Gietl, Anton et al. · 2017 · The Lancet Neurology
25. Tau PET imaging in neurodegenerative tauopathies—still a challenge
    Leuzy, Antoine, Chiotis, Konstantinos, Lemoine, Laetitia, Gillberg, Per-Göran, Almkvist, Ove, Rodriguez-Vieitez, Elena, Nordberg, Agneta · 2019 · Molecular Psychiatry
26. A review on neuroimaging-based classification studies and associated feature extraction methods for Alzheimer's disease and its prodromal stages
    Rathore, Saima, Habes, Mohamad, Iftikhar, Muhammad Aksam, Shacklett, Amanda, Davatzikos, Christos · 2017 · NeuroImage
27. The Alzheimer’s Disease Clinical Spectrum
    Atri, Alireza · 2019 · Medical Clinics of North America
28. Amyloid-Related Imaging Abnormalities in 2 Phase 3 Studies Evaluating Aducanumab in Patients with Early Alzheimer Disease
    Salloway, Stephen, Chalkias, Spyros, Barkhof, Frederik, Burkett, Patrick, Barakos, Jerome, Purcell, Derk, Suhy, Joyce, Forrestal, Fiona, Tian, Ying, Umans, Kimberly et al. · 2022 · JAMA Neurology
29. Molecular genetics of early-onset Alzheimer’s disease revisited
    Cacace, Rita, Sleegers, Kristel, Van Broeckhoven, Christine · 2016 · Alzheimer's &amp; Dementia
30. APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic cases
    Lanoiselée, Hélène-Marie, Nicolas, Gaël, Wallon, David, Rovelet-Lecrux, Anne, Lacour, Morgane, Rousseau, Stéphane, Richard, Anne-Claire, Pasquier, Florence, Rollin-Sillaire, Adeline, Martinaud, Olivier et al. · 2017 · PLOS Medicine
31. Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study
    Thijssen, Elisabeth H, La Joie, Renaud, Strom, Amelia, Fonseca, Corrina, Iaccarino, Leonardo, Wolf, Amy, Spina, Salvatore, Allen, Isabel E, Cobigo, Yann, Heuer, Hilary et al. · 2021 · The Lancet Neurology
32. Relation of cerebral vessel disease to Alzheimer's disease dementia and cognitive function in elderly people: a cross-sectional study
    Arvanitakis, Zoe, Capuano, Ana W, Leurgans, Sue E, Bennett, David A, Schneider, Julie A · 2016 · The Lancet Neurology
33. Appropriate use criteria for amyloid PET: a report of the amyloid imaging task force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association
    Johnson, Keith A., Minoshima, Satoshi, Bohnen, Nicolaas I., Donohoe, Kevin J., Foster, Norman L., Herscovitch, Peter, Karlawish, Jason H., Rowe, Christopher C., Carrillo, Maria C., Hartley, Dean M. et al. · 2013 · Alzheimer's &amp; Dementia
34. Implementation of subjective cognitive decline criteria in research studies
    Molinuevo, José L., Rabin, Laura A., Amariglio, Rebecca, Buckley, Rachel, Dubois, Bruno, Ellis, Kathryn A., Ewers, Michael, Hampel, Harald, Klöppel, Stefan, Rami, Lorena et al. · 2017 · Alzheimer's &amp; Dementia
35. Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and <i>APOE</i> genotype
    Vermunt, Lisa, Sikkes, Sietske A.M., van den Hout, Ardo, Handels, Ron, Bos, Isabelle, van der Flier, Wiesje M., Kern, Silke, Ousset, Pierre‐Jean, Maruff, Paul, Skoog, Ingmar et al. · 2019 · Alzheimer's &amp; Dementia
36. Is the Montreal Cognitive Assessment (MoCA) screening superior to the Mini-Mental State Examination (MMSE) in the detection of mild cognitive impairment (MCI) and Alzheimer’s Disease (AD) in the elderly?
    Tiago Coimbra Costa Pinto, Leonardo Machado, Tatiana M. Bulgacov, A. L. Rodrigues, María Lúcia Gurgel da Costa, Rosana Christine Cavalcanti Ximenes, Éverton Botelho Sougey · 2018 · International Psychogeriatrics
37. Alzheimer's Disease: Treatment Strategies and Their Limitations.
    Passeri, Elodie, Elkhoury, Kamil, Morsink, Margaretha, Broersen, Kerensa, Linder, Michel, Tamayol, Ali, Malaplate, Catherine, Yen, Frances T., Arab-Tehrany, Elmira · 2022 · International Journal of Molecular Sciences
38. A Deep Learning Model to Predict a Diagnosis of Alzheimer Disease by Using ¹⁸ F-FDG PET of the Brain
    Ding, Yiming, Sohn, Jae Ho, Kawczynski, Michael G., Trivedi, Hari, Harnish, Roy, Jenkins, Nathaniel W., Lituiev, Dmytro, Copeland, Timothy P., Aboian, Mariam S., Mari Aparici, Carina et al. · 2019 · Radiology
39. The road to restoring neural circuits for the treatment of Alzheimer's disease
    Canter, Rebecca G., Penney, Jay, Tsai, Li-Huei · 2016 · Nature
40. At the interface of sensory and motor dysfunctions and Alzheimer’s disease.
    Albers, Mark W., Gilmore, Grover C., Kaye, Jeffrey, Murphy, Claire, Wingfield, Arthur, Bennett, David A., Boxer, Adam L., Buchman, Aron S., Cruickshanks, Karen J., Devanand, Davangere P. et al. · 2015 · Alzheimer's &amp; Dementia
41. Advantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer’s Disease
    Hansson, Oskar, Lehmann, Sylvain, Otto, Markus, Zetterberg, Henrik, Lewczuk, Piotr · 2019 · Alzheimer's Research &amp; Therapy
42. Posterior cortical atrophy
    Sebastian James Crutch, Manja Lehmann, Jonathan M. Schott, Gil Dan Rabinovici, Martin N. Rossor, Nick C. Fox · 2012 · The Lancet Neurology
43. Disruption of the Sleep-Wake Cycle and Diurnal Fluctuation of β-Amyloid in Mice with Alzheimer’s Disease Pathology
    Roh, Jee Hoon, Huang, Yafei, Bero, Adam W., Kasten, Tom, Stewart, Floy R., Bateman, Randall J., Holtzman, David M. · 2012 · Science Translational Medicine
44. The behavioural/dysexecutive variant of Alzheimer’s disease: clinical, neuroimaging and pathological features
    Ossenkoppele, Rik, Pijnenburg, Yolande A. L., Perry, David C., Cohn-Sheehy, Brendan I., Scheltens, Nienke M. E., Vogel, Jacob W., Kramer, Joel H., van der Vlies, Annelies E., Joie, Renaud La, Rosen, Howard J. et al. · 2015 · Brain
45. The Neuropsychological Profile of Alzheimer Disease
    Sandra Weıntraub, Alissa H. Wicklund, David P. Salmon · 2012 · Cold Spring Harbor Perspectives in Medicine
46. Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study
    Vos, Stephanie JB, Xiong, Chengjie, Visser, Pieter Jelle, Jasielec, Mateusz S, Hassenstab, Jason, Grant, Elizabeth A, Cairns, Nigel J, Morris, John C, Holtzman, David M, Fagan, Anne M · 2013 · The Lancet Neurology
47. Incidence and impact of subclinical epileptiform activity in Alzheimer’s disease.
    Vossel, Keith A., Ranasinghe, Kamalini G., Beagle, Alexander J., Mizuiri, Danielle, Honma, Susanne M., Dowling, Anne F., Darwish, Sonja M., Van Berlo, Victoria, Barnes, Deborah E., Mantle, Mary et al. · 2016 · Annals of Neurology
48. Clinical presentation of chronic traumatic encephalopathy
    Stern, Robert A., Daneshvar, Daniel H., Baugh, Christine M., Seichepine, Daniel R., Montenigro, Philip H., Riley, David O., Fritts, Nathan G., Stamm, Julie M., Robbins, Clifford A., McHale, Lisa et al. · 2013 · Neurology
49. Timely Diagnosis for Alzheimer’s Disease: A Literature Review on Benefits and Challenges
    Bruno Dubois, Alessandro Padovani, Philip Scheltens, Andrea Rossi, Grazia Dell’Agnello · 2015 · Journal of Alzheimer s Disease
50. Long‐term Consequences of Repetitive Brain Trauma: Chronic Traumatic Encephalopathy
    Robert A. Stern, David Riley, Daniel Hamed Daneshvar, Christopher J. Nowinski, Robert C. Cantu, Ann Carolyn McKee · 2011 · PM&R
51. Estimating the Prevalence of Dementia and Mild Cognitive Impairment in the US: The 2016 Health and Retirement Study Harmonized Cognitive Assessment Protocol Project
    Manly, Jennifer J., Jones, Richard N., Langa, Kenneth M., Ryan, Lindsay H., Levine, Deborah A., McCammon, Ryan, Heeringa, Steven G., Weir, David · 2022 · JAMA Neurology
52. On the path to 2025: understanding the Alzheimer’s disease continuum
    Aisen, Paul S., Cummings, Jeffrey, Jack, Clifford R., Morris, John C., Sperling, Reisa, Frölich, Lutz, Jones, Roy W., Dowsett, Sherie A., Matthews, Brandy R., Raskin, Joel et al. · 2017 · Alzheimer's Research &amp; Therapy
53. Epidemiology of Dementias and Alzheimer’s Disease
    Ana Luisa Sosa, Isaac Acosta, Martin James Prince · 2012 · Archives of Medical Research
54. Perspectives on ethnic and racial disparities in Alzheimer's disease and related dementias: update and areas of immediate need
    Babulal, Ganesh M., Quiroz, Yakeel T., Albensi, Benedict C., Arenaza‐Urquijo, Eider, Astell, Arlene J., Babiloni, Claudio, Bahar‐Fuchs, Alex, Bell, Joanne, Bowman, Gene L., Brickman, Adam M. et al. · 2019 · Alzheimer's &amp; Dementia
55. Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias
    Chételat, Gaël, Arbizu, Javier, Barthel, Henryk, Garibotto, Valentina, Law, Ian, Morbelli, Silvia, van de Giessen, Elsmarieke, Agosta, Federica, Barkhof, Frederik, Brooks, David J et al. · 2020 · The Lancet Neurology
56. sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early‐stage Alzheimer's disease and associate with neuronal injury markers
    Suárez‐Calvet, Marc, Kleinberger, Gernot, Araque Caballero, Miguel Ángel, Brendel, Matthias, Rominger, Axel, Alcolea, Daniel, Fortea, Juan, Lleó, Alberto, Blesa, Rafael, Gispert, Juan Domingo et al. · 2016 · EMBO Molecular Medicine
57. Head-to-head comparison of 10 plasma phospho-tau assays in prodromal Alzheimer’s disease
    Janelidze, Shorena, Bali, Divya, Ashton, Nicholas J, Barthélemy, Nicolas R, Vanbrabant, Jeroen, Stoops, Erik, Vanmechelen, Eugeen, He, Yingxin, Dolado, Anna Orduña, Triana-Baltzer, Gallen et al. · 2023 · Brain
58. State of the science on mild cognitive impairment (MCI)
    Nicole D. Anderson · 2019 · CNS Spectrums
59. The preclinical phase of the pathological process underlying sporadic Alzheimer’s disease
    Braak, Heiko, Del Tredici, Kelly · 2015 · Brain
60. Hippocampal insulin resistance and cognitive dysfunction
    Geert Jan Biessels, Lawrence Patrick Reagan · 2015 · Nature reviews. Neuroscience
61. The mild behavioral impairment checklist (MBI-C): A rating scale for neuropsychiatric symptoms in pre-dementia populations
    Ismail, Zahinoor, for the NPS Professional Interest Area of the International Society of to Advance Alzheimer’s Research and Treatment (NPS-PIA of ISTAART), Agüera-Ortiz, Luis, Brodaty, Henry, Cieslak, Alicja, Cummings, Jeffrey, Fischer, Corinne E., Gauthier, Serge, Geda, Yonas E., Herrmann, Nathan et al. · 2017 · Journal of Alzheimer's Disease
62. Current state of Alzheimer’s fluid biomarkers
    Molinuevo, José Luis, Ayton, Scott, Batrla, Richard, Bednar, Martin M., Bittner, Tobias, Cummings, Jeffrey, Fagan, Anne M., Hampel, Harald, Mielke, Michelle M., Mikulskis, Alvydas et al. · 2018 · Acta Neuropathologica
63. Dementia: timely diagnosis and early intervention
    Robinson, L., Tang, E., Taylor, J.-P. · 2015 · BMJ
64. Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline
    Ossenkoppele, Rik, Pichet Binette, Alexa, Groot, Colin, Smith, Ruben, Strandberg, Olof, Palmqvist, Sebastian, Stomrud, Erik, Tideman, Pontus, Ohlsson, Tomas, Jögi, Jonas et al. · 2022 · Nature Medicine
65. AD dementia risk in late MCI, in early MCI, and in subjective memory impairment.
    Jessen, Frank, Wolfsgruber, Steffen, Wiese, Birgitt, Bickel, Horst, Mösch, Edelgard, Kaduszkiewicz, Hanna, Pentzek, Michael, Riedel‐Heller, Steffi G., Luck, Tobias, Fuchs, Angela et al. · 2014 · Alzheimer's &amp; Dementia
66. Differences Between Women and Men in Incidence Rates of Dementia and Alzheimer’s Disease
    Beam, Christopher R., Kaneshiro, Cody, Jang, Jung Yun, Reynolds, Chandra A., Pedersen, Nancy L., Gatz, Margaret · 2018 · Journal of Alzheimer’s Disease
67. Prediction of future Alzheimer’s disease dementia using plasma phospho-tau combined with other accessible measures
    Palmqvist, Sebastian, Tideman, Pontus, Cullen, Nicholas, Zetterberg, Henrik, Blennow, Kaj, the Alzheimer’s Disease Neuroimaging Initiative, Dage, Jeffery L., Stomrud, Erik, Janelidze, Shorena, Mattsson-Carlgren, Niklas et al. · 2021 · Nature Medicine
68. Version 3 of the National Alzheimer’s Coordinating Center’s Uniform Data Set
    Lilah M. Besser, Walter A. Kukull, David S. Knopman, Helena Chang Chui, Douglas Galasko, Sandra Weıntraub, Gregory A. Jicha, Cynthia M. Carlsson, Jeffrey Murray Burns, Joseph F. Quinn et al. · 2018 · Alzheimer Disease & Associated Disorders
69. 3D-CAM: Derivation and Validation of a 3-Minute Diagnostic Interview for CAM-Defined Delirium
    Edward R. Marcantonio, Long H. Ngo, Margaret G. O’Connor, Richard Norman Jones, Paul K. Crane, Eran D. Metzger, Sharon K. Inouye · 2014 · Annals of Internal Medicine
70. Discriminative Accuracy of [ ¹⁸ F]flortaucipir Positron Emission Tomography for Alzheimer Disease vs Other Neurodegenerative Disorders
    Ossenkoppele, Rik, Rabinovici, Gil D., Smith, Ruben, Cho, Hanna, Schöll, Michael, Strandberg, Olof, Palmqvist, Sebastian, Mattsson, Niklas, Janelidze, Shorena, Santillo, Alexander et al. · 2018 · JAMA
71. Cognitive training and cognitive rehabilitation for mild to moderate Alzheimer's disease and vascular dementia
    Bahar-Fuchs, Alex, Clare, Linda, Woods, Bob · 2013 · Cochrane Database of Systematic Reviews
72. Twenty-seven-year time trends in dementia incidence in Europe and the United States: The Alzheimer Cohorts Consortium
    Wolters, Frank J., Chibnik, Lori B., Waziry, Reem, Anderson, Roy, Berr, Claudine, Beiser, Alexa, Bis, Joshua C., Blacker, Deborah, Bos, Daniel, Brayne, Carol et al. · 2020 · Neurology
73. Functional network disruption in the degenerative dementias
    Pievani, Michela, de Haan, Willem, Wu, Tao, Seeley, William W, Frisoni, Giovanni B · 2011 · The Lancet Neurology
74. An autoradiographic evaluation of AV-1451 Tau PET in dementia
    Lowe, Val J., Curran, Geoffry, Fang, Ping, Liesinger, Amanda M., Josephs, Keith A., Parisi, Joseph E., Kantarci, Kejal, Boeve, Bradley F., Pandey, Mukesh K., Bruinsma, Tyler et al. · 2016 · Acta Neuropathologica Communications
75. Identifying dementia outcomes in UK Biobank: A validation study of primary care, hospital admissions and mortality data
    on behalf of Dementias Platform UK and UK Biobank, Wilkinson, Tim, Schnier, Christian, Bush, Kathryn, Rannikmäe, Kristiina, Henshall, David E., Lerpiniere, Chris, Allen, Naomi E., Flaig, Robin, Russ, Tom C. et al. · 2019 · European Journal of Epidemiology
76. Chronic traumatic encephalopathy: Neurodegeneration following repetitive concussive and subconcussive brain trauma
    Baugh, Christine M., Stamm, Julie M., Riley, David O., Gavett, Brandon E., Shenton, Martha E., Lin, Alexander, Nowinski, Christopher J., Cantu, Robert C., McKee, Ann C., Stern, Robert A. · 2012 · Brain Imaging and Behavior
77. Subjective cognitive complaints and amyloid burden in cognitively normal older individuals
    Amariglio, Rebecca E., Becker, J. Alex, Carmasin, Jeremy, Wadsworth, Lauren P., Lorius, Natacha, Sullivan, Caroline, Maye, Jacqueline E., Gidicsin, Christopher, Pepin, Lesley C., Sperling, Reisa A. et al. · 2012 · Neuropsychologia
78. Amyloid biomarkers in Alzheimer's disease
    Blennow, Kaj, Mattsson, Niklas, Schöll, Michael, Hansson, Oskar, Zetterberg, Henrik · 2015 · Trends in Pharmacological Sciences
79. Moderate alcohol consumption as risk factor for adverse brain outcomes and cognitive decline: longitudinal cohort study
    Topiwala, Anya, Allan, Charlotte L, Valkanova, Vyara, Zsoldos, Enikő, Filippini, Nicola, Sexton, Claire, Mahmood, Abda, Fooks, Peggy, Singh-Manoux, Archana, Mackay, Clare E et al. · 2017 · BMJ
80. Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer’s disease
    Chatterjee, Pratishtha, Pedrini, Steve, Stoops, Erik, Goozee, Kathryn, Villemagne, Victor L., Asih, Prita R., Verberk, Inge M. W., Dave, Preeti, Taddei, Kevin, Sohrabi, Hamid R. et al. · 2021 · Translational Psychiatry
81. The gut microbiota-derived metabolite trimethylamine N-oxide is elevated in Alzheimer’s disease
    Vogt, Nicholas M., Romano, Kymberleigh A., Darst, Burcu F., Engelman, Corinne D., Johnson, Sterling C., Carlsson, Cynthia M., Asthana, Sanjay, Blennow, Kaj, Zetterberg, Henrik, Bendlin, Barbara B. et al. · 2018 · Alzheimer's Research &amp; Therapy
82. The short-term and long-term relationship between delirium and cognitive trajectory in older surgical patients
    Inouye, Sharon K., Marcantonio, Edward R., Kosar, Cyrus M., Tommet, Douglas, Schmitt, Eva M., Travison, Thomas G., Saczynski, Jane S., Ngo, Long H., Alsop, David C., Jones, Richard N. · 2016 · Alzheimer's &amp; Dementia
83. Development and validation of an interpretable deep learning framework for Alzheimer’s disease classification
    Qiu, Shangran, Joshi, Prajakta S, Miller, Matthew I, Xue, Chonghua, Zhou, Xiao, Karjadi, Cody, Chang, Gary H, Joshi, Anant S, Dwyer, Brigid, Zhu, Shuhan et al. · 2020 · Brain
84. The Clinical Problem of Symptomatic Alzheimer Disease and Mild Cognitive Impairment
    Rawan M. Tarawneh, David M. Holtzman · 2012 · Cold Spring Harbor Perspectives in Medicine
85. Modeling Alzheimer’s disease with iPSC-derived brain cells
    Penney, Jay, Ralvenius, William T., Tsai, Li-Huei · 2020 · Molecular Psychiatry
86. Mini-Mental State Examination (MMSE) for the early detection of dementia in people with mild cognitive impairment (MCI)
    Ingrid Arévalo-Rodríguez, Nadja Smailagic, Marta Roqué i Figuls, Agustín Ciapponi, Erick Sanchez-Perez, Antri Giannakou, Olga Lucía Pedraza, Xavier Bonfill, Sarah J. Cullum · 2021 · Cochrane Database of Systematic Reviews
87. Subjective Cognitive Decline in Older Adults: An Overview of Self-Report Measures Used Across 19 International Research Studies
    Laura A. Rabin, the Alzheimer’s Disease Neuroimaging Initiative, Colette M. Smart, Paul K. Crane, Rebecca England Amariglio, Lorin Berman, Merçé Boada, Rachel F. Buckley, Gaël Chételat, Bruno Dubois et al. · 2015 · Journal of Alzheimer s Disease
88. Plasma Extracellular Vesicles Enriched for Neuronal Origin: A Potential Window into Brain Pathologic Processes
    Maja Mustapić, Erez Eitan, J. Kent Werner, Sean T. Berkowitz, Michael P. Lazaropoulos, Joyce Tran, Edward J. Goetzl, Dimitrios Kapogiannis · 2017 · Frontiers in Neuroscience
89. Assessing Synaptic Density in Alzheimer Disease With Synaptic Vesicle Glycoprotein 2A Positron Emission Tomographic Imaging
    Chen, Ming-Kai, Mecca, Adam P., Naganawa, Mika, Finnema, Sjoerd J., Toyonaga, Takuya, Lin, Shu-fei, Najafzadeh, Soheila, Ropchan, Jim, Lu, Yihuan, McDonald, Julia W. et al. · 2018 · JAMA Neurology
90. Performance of Fully Automated Plasma Assays as Screening Tests for Alzheimer Disease–Related β-Amyloid Status
    Palmqvist, Sebastian, Janelidze, Shorena, Stomrud, Erik, Zetterberg, Henrik, Karl, Johann, Zink, Katharina, Bittner, Tobias, Mattsson, Niklas, Eichenlaub, Udo, Blennow, Kaj et al. · 2019 · JAMA Neurology
91. Mental health care for older adults: recent advances and new directions in clinical practice and research
    Reynolds, Charles F., Jeste, Dilip V., Sachdev, Perminder S., Blazer, Dan G. · 2022 · World Psychiatry
92. Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative
    Veitch, Dallas P., Weiner, Michael W., Aisen, Paul S., Beckett, Laurel A., Cairns, Nigel J., Green, Robert C., Harvey, Danielle, Jack, Clifford R., Jagust, William, Morris, John C. et al. · 2019 · Alzheimer's &amp; Dementia
93. Biomarker Changes during 20 Years Preceding Alzheimer’s Disease
    Jia, Jianping, Ning, Yuye, Chen, Meilin, Wang, Shuheng, Yang, Hao, Li, Fangyu, Ding, Jiayi, Li, Yan, Zhao, Bote, Lyu, Jihui et al. · 2024 · New England Journal of Medicine
94. Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease
    Kaj Blennow, Bruno Dubois, Anne M. Fagan, Piotr Lewczuk, Mony J. de Leon, Harald Juergen Hampel · 2014 · Alzheimer s & Dementia
95. Random forest-based similarity measures for multi-modal classification of Alzheimer's disease
    Katherine R. Gray, Paul Aljabar, Rolf A. Heckemann, Alexander Hammers, Daniel Rueckert · 2012 · NeuroImage
96. Highly accurate blood test for Alzheimer's disease is similar or superior to clinical cerebrospinal fluid tests
    Barthélemy, Nicolas R., Salvadó, Gemma, Schindler, Suzanne E., He, Yingxin, Janelidze, Shorena, Collij, Lyduine E., Saef, Benjamin, Henson, Rachel L., Chen, Charles D., Gordon, Brian A. et al. · 2024 · Nature Medicine
97. Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's disease
    Maass, Anne, Landau, Susan, Baker, Suzanne L., Horng, Andy, Lockhart, Samuel N., La Joie, Renaud, Rabinovici, Gil D., Jagust, William J. · 2017 · NeuroImage
98. Longitudinal tau PET in ageing and Alzheimer’s disease
    Jack, Clifford R, Wiste, Heather J, Schwarz, Christopher G, Lowe, Val J, Senjem, Matthew L, Vemuri, Prashanthi, Weigand, Stephen D, Therneau, Terry M, Knopman, Dave S, Gunter, Jeffrey L et al. · 2018 · Brain
99. Nicotinic ACh receptors as therapeutic targets in CNS disorders
    Kelly T. Dineley, Anshul A. Pandya, Jerrel L. Yakel · 2015 · Trends in Pharmacological Sciences
100. Positron Emission Tomography Imaging With [ ¹⁸ F]flortaucipir and Postmortem Assessment of Alzheimer Disease Neuropathologic Changes
     Fleisher, Adam S., Pontecorvo, Michael J., Devous, Michael D., Lu, Ming, Arora, Anupa K., Truocchio, Stephen P., Aldea, Patricia, Flitter, Matthew, Locascio, Tricia, Devine, Marybeth et al. · 2020 · JAMA Neurology